Question
What will be the vaccine efficacy of the two-dose Johnson & Johnson Ad26.COV2.S vaccine candidate according to the results of Phase III testing?
Total Forecasters24
Community Prediction
89.8
(82.6 - 94.5)
Make a Prediction
CDF
This question is closed for predictions, and is waiting to be resolved
| Quartiles | community | My Prediction |
| lower 25% | 82.61 | — |
| median | 89.82 | — |
| upper 75% | 94.5 | — |
Authors:
Opened:Mar 12, 2021
Closed:Oct 4, 2021
Scheduled resolution:Feb 1, 2026
Spot Scoring Time:Mar 14, 2021
In what year will an HIV vaccine demonstrating at least 50% efficacy in Phase III clinical trials receive regulatory approval (e.g., from the FDA or EMA) for widespread use?
Jan 2035
Will the cancer pill AOH1996 enter Phase III clinical trials before January 1, 2027?
24.2%
When will an intranasal SARS-CoV-2 vaccine be approved by the US?
04 Aug 2026
Authors:
Opened:Mar 12, 2021
Closed:Oct 4, 2021
Scheduled resolution:Feb 1, 2026
Spot Scoring Time:Mar 14, 2021
In what year will an HIV vaccine demonstrating at least 50% efficacy in Phase III clinical trials receive regulatory approval (e.g., from the FDA or EMA) for widespread use?
Jan 2035
Will the cancer pill AOH1996 enter Phase III clinical trials before January 1, 2027?
24.2%
When will an intranasal SARS-CoV-2 vaccine be approved by the US?
04 Aug 2026